Bendamustine in Rituximab refractory FL
Kahl BS, et al.
Cancer.
2010;116(1):106-114.
100 patients rituximab refractory
Bendamustine: 120 mg/m
2
ORR: 75%
CR: 14%
Median PFS: 9 months